-+ 0.00%
-+ 0.00%
-+ 0.00%

Victoria's Secret (VSCO): Reassessing Valuation After Q3 Earnings Beat, Upgraded Guidance and Fashion Show Revival

Simply Wall St·12/15/2025 18:25:51
语音播报

Victoria's Secret (VSCO) just delivered a third quarter that beat Wall Street expectations, lifted by stronger sales, better margins, and a surprisingly effective boost from its revived Fashion Show and youth focused marketing.

See our latest analysis for Victoria's Secret.

The earnings beat and upgraded guidance have coincided with a sharp re-rating in the market, with a roughly 107% 90 day share price return and 18.7% one year total shareholder return suggesting momentum is clearly building.

If Victoria's Secret's turnaround has your attention, this could be a good moment to scout other retailers and discover fast growing stocks with high insider ownership.

With the stock at a three year high and trading slightly above the average analyst target but still at an implied discount to intrinsic value, is this momentum name a genuine buying opportunity, or is the market already pricing in the next leg of growth?

Most Popular Narrative Narrative: 74.6% Overvalued

Against the last close of $54.49, the most followed narrative implies a far lower fair value, framing today’s rally as well ahead of fundamentals.

The analysts have a consensus price target of $22.7 for Victoria's Secret based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $27.0, and the most bearish reporting a price target of just $17.0.

Read the complete narrative.

Curious how modest revenue growth, pressured margins and a richer future earnings multiple can still justify a much lower value than today’s price? Read on.

Result: Fair Value of $31.20 (OVERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, persistent tariff headwinds and renewed pressure on mall-based traffic could easily derail margin expansion and expose how fragile the current momentum is.

Find out about the key risks to this Victoria's Secret narrative.

Another View: Market Multiples Paint a Richer Picture

Step away from narrative fair values and the current price tag looks punchy. Victoria's Secret trades on a 25.7x earnings ratio, versus 20.2x for the US specialty retail group and a 22.2x fair ratio, suggesting the market is already baking in a lot of good news.

See what the numbers say about this price — find out in our valuation breakdown.

NYSE:VSCO PE Ratio as at Dec 2025
NYSE:VSCO PE Ratio as at Dec 2025

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Victoria's Secret for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 907 undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Build Your Own Victoria's Secret Narrative

If this perspective does not quite align with your own thinking, or you prefer to dig into the numbers yourself, you can build a custom narrative in just a few minutes: Do it your way.

A great starting point for your Victoria's Secret research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.

Ready for more investment ideas?

Before you move on, consider your next opportunities with focused stock ideas that match your strategy, instead of leaving potential gains on the table.

  • Explore early growth stories by reviewing these 3612 penny stocks with strong financials, which highlight companies pairing lower share prices with balance sheets and cash flows that can support the next phase of expansion.
  • Look into the AI revolution through these 30 healthcare AI stocks, identifying companies using intelligent tools to improve diagnostics, treatment pathways, and long term patient outcomes.
  • Evaluate income opportunities and potential capital upside using these 13 dividend stocks with yields > 3%, focusing on businesses that combine yields with fundamentals that may support payouts across different market conditions.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.